Clinical trial
Dendritic Cell Vaccine in HIV-1 Infection
NCT00402142 · Hospital Clinic of Barcelona, Other · Completed
Key facts
| NCT number | NCT00402142 |
|---|---|
| Title | Dendritic Cell Vaccine in HIV-1 Infection |
| Official title | Phase II Study of Autologous Myeloid Dendritic Cells as a "Cellular Adjuvant" for a Therapeutic HIV-1 Vaccine in Early Stage HIV-1+ Patients (DCV-2). |
| Lead sponsor | Hospital Clinic of Barcelona, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Biological |
| Interventions | Dendritic cell vaccine, non pulsed dendritic cell untreated patients, pulsed dendritic cell vaccine, dendritic cell vaccine, non pulsed dendritic cell vaccine |
| Enrollment | 60 |
| Start date | Nov 1, 2006 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Nov 22, 2006 |
| Last update posted | Feb 26, 2014 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: